Vascular resection in the surgical treatment of pancreatic adenocarcinoma; experience of a center

s / Pancreatology S90 location (52.4%), size more than 3 cm (76.1%) and most of the cases were (58.6%) stadia IV. Treatment: 37.8% chemotherapy, 12.6% surgery and 49.6% palliative. The mean of follow-up was 5.3 months, in this time 95 patients die. Median survival was 3.9 months. Conclusion: -RNL can provide prognosis relevant information. It can be calculated from analytical data so it is very easy to obtain and it is and objective value. RNL is useful for all patients, regardless of the treatment given.